A review of addiction
Abstract
Addiction to drugs and alcohol is often undiagnosed and untreated. Physicians are often unaware or have negative attitudes regarding these patients, such as the perception that treatment is ineffective. Addiction--psychological dependence with or without tolerance and withdrawal--is essentially compulsive uncontrolled substance use despite physical, psychological, or social consequences. We now have an understanding of the 2 major neurological pathways involved in addiction. First, the mesolimbic dopamine reward pathway, which is essential for survival, can be physically altered by drug abuse to result in uncontrolled cravings. Second, the decision-making prefrontal cortex, which suppresses inappropriate reward response, can also be altered by drug abuse. Thus, accelerated "go" signals and impaired "stop" signals result in uncontrolled use despite severe consequences. Further, addicts can be predisposed to addiction by genetic defects in reward pathway neurotransmission and stress-related developmental brain abnormalities. Relapse to drug use can occur because of stress or cue-related reward pathway stimulation or even by a single drug dose. Individualized treatment of addiction, including pharmacological and cognitive-behavioral interventions, can be as successful as treatment of other chronic diseases. Several pharmaceuticals are available or under study for these disorders. Waiting for the addict to "be ready" for treatment can be dangerous and detoxification alone is often ineffective. The physician's role in treating addiction includes prevention, diagnosis, brief intervention, motivational interviewing, referral, and follow-up care. An understanding of the biological reality of addiction allows physicians to understand addicts as having a brain disease. Further, the reality of effective pharmacological and cognitive-behavioral treatments for addiction allows physicians to be more optimistic in treating addicts. The challenge to the physician is to embrace the reality of addictive disease and fulfill his or her role in its treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The two most commonly used psychotherapeutic approaches to addiction therapy are motivational interviewing and cognitive behavioral therapy.
“The two most commonly used psychotherapeutic approaches to addition therapy are motivation interview therapy (Hettema et al., 2005) and cognitive behavioral therapy (Clay et al., 2008).”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Clay et al., 2008
Cited by
Sorted by citations
Impulsivity, frontal lobes and risk for addiction
Crews, F. T., & Boettiger, C. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.018 · Cited by 679 · see citing works
“The two most commonly used psychotherapeutic approaches to addition therapy are motivation interview therapy (Hettema et al., 2005) and cognitive behavioral therapy (Clay et al., 2008).”
MethodThe plausibility of sugar addiction and its role in obesity and eating disorders
Benton, D. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.001 · Cited by 144 · see citing works
- Authors
- Clay, S.
- Affiliations
- Ohio University (US)
- Corresponding author
- Clay, Steven
- Venue
- Postgraduate Medicine
- Publisher
- Informa UK Limited
- Published
- 2008-07-15
- Volume
- 120
- Issue
- 2
- Pages
- E01-7
- ISSN
- 0032-5481 (ISSN-L)
- 1941-9260
- OpenAlex
- W1995971654
- Cited by
- 51
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 1 · 2020: 4 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 2 · 2013: 3 · 2012: 2
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Postgraduate Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- addiction, substance use disorders, drug addiction, alcoholism, prefrontal cortex, decision-making, relapse, genetic predisposition to addiction, stress, pharmacotherapy, cognitive behavioral therapy, motivational interviewing, brief intervention
- MeSH terms
- Dopamine, Humans, Limbic System, Mesencephalon, Risk Factors, Behavior, Addictive, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review